119 related articles for article (PubMed ID: 10220278)
1. Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actions.
Uda K; Kobayashi Y; Hisada T; Orlowski RC; Bastian JW; Arnaud CD; Wakabayashi K
Biol Pharm Bull; 1999 Mar; 22(3):244-52. PubMed ID: 10220278
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
[TBL] [Abstract][Full Text] [Related]
3. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
4. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
5. Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals.
Yamashita T; Udagawa N; Thirukonda GJ; Uehara S; Yamauchi H; Suzuki N; Li F; Kobayashi Y; Takahashi N
Gen Comp Endocrinol; 2017 May; 246():270-278. PubMed ID: 28062306
[TBL] [Abstract][Full Text] [Related]
6. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
7. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
[TBL] [Abstract][Full Text] [Related]
8. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
Orlowski RC; Epand RM; Stafford AR
Eur J Biochem; 1987 Jan; 162(2):399-402. PubMed ID: 3803393
[TBL] [Abstract][Full Text] [Related]
9. The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids.
Epand RF; Orlowski RC; Epand RM
Biopolymers; 2004; 76(3):258-65. PubMed ID: 15148685
[TBL] [Abstract][Full Text] [Related]
10. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
Azuma Y; Chokki M; Ohta T; Kiyoki M
Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
[TBL] [Abstract][Full Text] [Related]
11. [Centrally and peripherally induced anorectic actions of salmon calcitonin (sCT) in rats: separation of its novel derivative [Gly8]-sCT].
Nakamuta H; Koida M; Ogawa Y; Orlowski RC
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):191-5. PubMed ID: 3038715
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of human calcitonin-gene-related peptide.
Zaidi M; Brain SD; Tippins JR; Di Marzo V; Moonga BS; Chambers TJ; Morris HR; MacIntyre I
Biochem J; 1990 Aug; 269(3):775-80. PubMed ID: 2390067
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin of the stingray: comparison of the hypocalcemic activity with other calcitonins.
Sasayama Y; Suzuki N; Oguro C; Takei Y; Takahashi A; Watanabe TX; Nakajima K; Sakakibara S
Gen Comp Endocrinol; 1992 May; 86(2):269-74. PubMed ID: 1601276
[TBL] [Abstract][Full Text] [Related]
14. Primary structure and bioactivity of bullfrog calcitonin.
Yoshida A; Kaiya H; Takei Y; Watanabe TX; Nakajima K; Suzuki N; Sasayama Y
Gen Comp Endocrinol; 1997 Aug; 107(2):147-52. PubMed ID: 9245522
[TBL] [Abstract][Full Text] [Related]
15. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
Kapurniotu A; Taylor JW
J Med Chem; 1995 Mar; 38(5):836-47. PubMed ID: 7877149
[TBL] [Abstract][Full Text] [Related]
16. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
[TBL] [Abstract][Full Text] [Related]
17. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt.
Kazantzis A; Waldner M; Taylor JW; Kapurniotu A
Eur J Biochem; 2002 Feb; 269(3):780-91. PubMed ID: 11846779
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic semisynthesis of dicarba analogs of calcitonin.
Cerovský V; Wünsch E; Brass J
Eur J Biochem; 1997 Jul; 247(1):231-7. PubMed ID: 9249031
[TBL] [Abstract][Full Text] [Related]
19. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues.
Kapurniotu A; Kayed R; Taylor JW; Voelter W
Eur J Biochem; 1999 Oct; 265(2):606-18. PubMed ID: 10504392
[TBL] [Abstract][Full Text] [Related]
20. Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange.
Nabuchi Y; Asoh Y; Takayama M
J Am Soc Mass Spectrom; 2004 Nov; 15(11):1556-64. PubMed ID: 15519222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
